Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATORVASTATIN Cause Mean cell haemoglobin concentration abnormal? 9 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Mean cell haemoglobin concentration abnormal have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.0% of all adverse event reports for ATORVASTATIN.

9
Reports of Mean cell haemoglobin concentration abnormal with ATORVASTATIN
0.0%
of all ATORVASTATIN reports
0
Deaths
0
Hospitalizations

How Dangerous Is Mean cell haemoglobin concentration abnormal From ATORVASTATIN?

Of the 9 reports.

Is Mean cell haemoglobin concentration abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does ATORVASTATIN Cause?

Type 2 diabetes mellitus (7,556) Myalgia (7,155) Drug hypersensitivity (3,929) Drug ineffective (3,865) Fatigue (3,439) Arthralgia (3,338) Rhabdomyolysis (3,286) Dyspnoea (3,137) Nausea (2,888) Asthenia (2,791)

What Other Drugs Cause Mean cell haemoglobin concentration abnormal?

ETANERCEPT (19) PREDNISONE (18) ADALIMUMAB (16) METHOTREXATE (16) TOFACITINIB (14) ECULIZUMAB (12) HERBALS\TURMERIC (12) LEFLUNOMIDE (12) NABILONE (12) ERGOCALCIFEROL (11)

Which ATORVASTATIN Alternatives Have Lower Mean cell haemoglobin concentration abnormal Risk?

ATORVASTATIN vs ATORVASTATIN\EZETIMIBE ATORVASTATIN vs ATOSIBAN ATORVASTATIN vs ATOVAQUONE ATORVASTATIN vs ATOVAQUONE\PROGUANIL ATORVASTATIN vs ATRACURIUM

Related Pages

ATORVASTATIN Full Profile All Mean cell haemoglobin concentration abnormal Reports All Drugs Causing Mean cell haemoglobin concentration abnormal ATORVASTATIN Demographics